Search Results 101-110 of 17588 for Hepatitis C

  1. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 ...

  2. Hepatitis a and hepatitis b vaccine (intramuscular route) - Mayo Clinic

    Hepatitis A is a serious disease of the liver that can cause death. It is caused by the hepatitis A virus (HAV), and is spread most often through infected food ...

  3. Publications - W Ray Kim, M.D. - Mayo Clinic

    ... Hepatitis C Virus Infection in the United States. Transplantation. 2018 Mar; 102 (3):454-460. View PubMed; Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA ...

  4. Hepatitis a vaccine (intramuscular route) - Mayo Clinic

    Hepatitis A is a serious disease of the liver that can cause death. It is caused by the hepatitis A virus (HAV), and is spread most often through infected food ...

  5. Liver Transplant Clinical Trials - Mayo Clinic Research

    A Study to Evaluate Preemptive Therapy in Hepatitis C Organ Transplant Recipients Scottsdale/Phoenix, AZ; Jacksonville, FL.

  6. Gilead Sustained Virologic Response (SVR) Registry - Mayo Clinic

    ... Hepatitis C Virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV. Participation eligibility. Participant ...

  7. Vasculitis - Symptoms and causes - Mayo Clinic

    Infections, such as hepatitis B and hepatitis C. Blood cancers. Immune system diseases, such as rheumatoid arthritis, lupus and scleroderma. Reactions to ...

  8. Hepatitis B Clinical Trials - Mayo Clinic Research

    The purpose of this study is to find the rate of Hepatitis B, Hepatitis C, and Hepatocellular Carcinoma in individual populations of African descendants living ...

  9. And it can lead to hepatitis B and hepatitis C, which can raise the risk of liver cancer. If you need help with drug misuse or addiction, talk with a ...

  10. Liver Hemangioma Clinical Trials - Mayo Clinic Research

    Secondary outcomes are rate of recurrence of Hepatitis C, problems related to wound healing, hernia repair within the first 12 months, hepatic arterial ...